» Articles » PMID: 32423664

A Close-up on COVID-19 and Cardiovascular Diseases

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: To analyze the potential mechanism of cardiovascular dysfunctions induced by Coronavirus Disease 2019 (COVID-19) and to evaluate more effective therapeutic pathways for patients with cardiovascular diseases.

Data Synthesis: COVID-19 mainly invades the lungs, causing its serious damage. Studies found that COVID-19 induced the renin-angiotensin system imbalance, inflammatory storm, hypoxemia, stress response, and so on; all contributed to hypertension and serious myocardial damage in the process of virus pathogenesis, even increasing mortality in COVID-19 patients.

Conclusion: In the process of management of COVID-19 infections, close attention should be paid on both lung and cardiovascular damage, especially on those with only symptoms of cardiovascular diseases. Early identification, timely and effective treatments, and maintenance of hemodynamics and electrophysiological stability are of great significance on effective treatment and long-term prognosis.

Citing Articles

QbD-steered HPTLC approach for concurrent estimation of six co-administered COVID-19 and cardiovascular drugs in different matrices: greenness appraisal.

Mohamed A, Sayed R, Shalaby A, Ibrahim H Sci Rep. 2025; 15(1):6252.

PMID: 39979403 PMC: 11842590. DOI: 10.1038/s41598-024-83692-x.


Clinical and echocardiographic findings in patients with COVID-19 across different severity levels.

Hryzhak I, Pryshliak O, Kobryn T, Fedorov S, Boichuk O, Marynchak O J Med Life. 2024; 16(11):1692-1700.

PMID: 38406777 PMC: 10893567. DOI: 10.25122/jml-2023-0206.


Optimal evaluation of re-opening policies for COVID-19 through the use of metaheuristic schemes.

Cuevas E, Rodriguez A, Perez M, Murillo-Olmos J, Morales-Castaneda B, Alejo-Reyes A Appl Math Model. 2023; 121:506-523.

PMID: 37234701 PMC: 10199305. DOI: 10.1016/j.apm.2023.05.012.


An agent-based transmission model of COVID-19 for re-opening policy design.

Rodriguez A, Cuevas E, Zaldivar D, Morales-Castaneda B, Sarkar R, Houssein E Comput Biol Med. 2022; 148:105847.

PMID: 35932728 PMC: 9293792. DOI: 10.1016/j.compbiomed.2022.105847.


Endothelial dysfunction assessed by brachial artery flow-mediated dilatation predicts severe COVID-19-related disease.

Walia R, Arunachalam V, Chauhan U, Khapre M, Arora P J Family Med Prim Care. 2022; 11(1):319-324.

PMID: 35309652 PMC: 8930105. DOI: 10.4103/jfmpc.jfmpc_281_21.


References
1.
Zhu N, Zhang D, Wang W, Li X, Yang B, Song J . A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020; 382(8):727-733. PMC: 7092803. DOI: 10.1056/NEJMoa2001017. View

2.
Azhar E, Hui D, Memish Z, Drosten C, Zumla A . The Middle East Respiratory Syndrome (MERS). Infect Dis Clin North Am. 2019; 33(4):891-905. PMC: 7127753. DOI: 10.1016/j.idc.2019.08.001. View

3.
Ishiyama Y, Gallagher P, Averill D, Tallant E, Brosnihan K, Ferrario C . Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors. Hypertension. 2004; 43(5):970-6. DOI: 10.1161/01.HYP.0000124667.34652.1a. View

4.
Hui D, Zumla A . Severe Acute Respiratory Syndrome: Historical, Epidemiologic, and Clinical Features. Infect Dis Clin North Am. 2019; 33(4):869-889. PMC: 7127569. DOI: 10.1016/j.idc.2019.07.001. View

5.
Channappanavar R, Perlman S . Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Semin Immunopathol. 2017; 39(5):529-539. PMC: 7079893. DOI: 10.1007/s00281-017-0629-x. View